BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 94 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $139,000 | -19.2% | 22,604 | -2.8% | 0.00% | 0.0% |
| Q2 2018 | $172,000 | +38.7% | 23,263 | +23.4% | 0.00% | 0.0% |
| Q1 2018 | $124,000 | -33.0% | 18,850 | -14.1% | 0.00% | 0.0% |
| Q4 2017 | $185,000 | -22.3% | 21,949 | +6.6% | 0.00% | -50.0% |
| Q3 2017 | $238,000 | +4.8% | 20,584 | +6.1% | 0.00% | 0.0% |
| Q2 2017 | $227,000 | +9.1% | 19,393 | +14.9% | 0.00% | 0.0% |
| Q1 2017 | $208,000 | -28.3% | 16,880 | -20.7% | 0.00% | -33.3% |
| Q4 2016 | $290,000 | -23.9% | 21,275 | +11.2% | 0.00% | -40.0% |
| Q3 2016 | $381,000 | +29.6% | 19,124 | -15.6% | 0.01% | +25.0% |
| Q2 2016 | $294,000 | +53.1% | 22,654 | +10.6% | 0.00% | +33.3% |
| Q1 2016 | $192,000 | -57.9% | 20,491 | -9.0% | 0.00% | -50.0% |
| Q4 2015 | $456,000 | – | 22,515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |